Edition:
United States

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

13.88USD
18 Dec 2018
Change (% chg)

-- (--)
Prev Close
$13.88
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
230,043
52-wk High
$17.93
52-wk Low
$4.24

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.24 December 19 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 3 3
(2) OUTPERFORM 2 2 2 2
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 1.75 1.86 1.86

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 7 2.89 11.03 1.00 2.08
Quarter Ending Mar-19 5 1.01 1.03 1.00 1.03
Year Ending Dec-18 7 5.95 14.11 4.00 4.93
Year Ending Dec-19 7 5.14 21.37 0.00 1.05
Earnings (per share)
Quarter Ending Dec-18 8 -0.24 -0.12 -0.34 -0.21
Quarter Ending Mar-19 4 -0.26 -0.17 -0.30 -0.26
Year Ending Dec-18 7 -1.19 -1.07 -1.29 -0.94
Year Ending Dec-19 8 -1.15 -0.71 -1.42 -1.09

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 2.87 1.03 1.84 64.23
Quarter Ending Jun-18 1.18 1.03 0.15 12.99
Quarter Ending Mar-18 1.68 1.06 0.62 36.92
Quarter Ending Dec-17 0.94 1.03 0.09 9.24
Quarter Ending Sep-17 0.94 1.03 0.08 8.86
Earnings (per share)
Quarter Ending Sep-18 -0.25 -0.31 0.06 -23.65
Quarter Ending Jun-18 -0.32 -0.37 0.05 -14.94
Quarter Ending Mar-18 -0.22 -0.27 0.05 -20.91
Quarter Ending Dec-17 -0.24 -0.29 0.05 -18.71
Quarter Ending Sep-17 -0.24 -0.26 0.02 -7.57

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 2.89 2.89 2.89 1.54 2.08
Quarter Ending Mar-19 1.01 1.01 1.01 1.01 1.03
Year Ending Dec-18 5.95 5.95 5.96 6.45 4.93
Year Ending Dec-19 5.14 5.14 5.15 5.32 1.05
Earnings (per share)
Quarter Ending Dec-18 -0.24 -0.24 -0.24 -0.28 -0.21
Quarter Ending Mar-19 -0.26 -0.26 -0.26 -0.28 -0.26
Year Ending Dec-18 -1.19 -1.19 -1.19 -1.17 -0.94
Year Ending Dec-19 -1.15 -1.15 -1.15 -1.21 -1.09

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 0 1
Year Ending Dec-19 0 0 0 1
Earnings
Quarter Ending Dec-18 0 0 0 1
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 1